NFL Veteran Mark Walczak Joins Medical Marijuana, Inc. Subsidiary Kannaway as Spokesperson

SAN DIEGO, March 28, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that former NFL Tight End and Snapper Mark Walczak has joined its subsidiary Kannaway® as a company spokesperson to help spread awareness on the benefits of hemp cannabidiol (CBD) for athletes and active consumers.

“Our athlete partnerships prove that CBD isn’t just something that’s trendy right now, it’s something that is actually helping people live their best lives every day,” said Kannaway® CEO Blake Schroeder. “We look forward to hearing about the continued success that Mark Walczak has with our CBD Salve, Gold and Premium CBD Oral Applicators, and Pure CBD Liquid.”

Walczak played five NFL seasons for the Indianapolis Colts, Buffalo Bills, Phoenix Cardinals, and San Diego Chargers and was inducted into the New York State Section 5 High School Football Hall of Fame. Since being retired, he started his own real estate company and is actively working with several other NFL legends to help improve the health of former professional athletes through promoting Sleep Apnea awareness for testing and treatment across the country.

“There’s a lot of wear and tear on my body from playing football professionally and when I found Kannaway I was looking for something natural to help me tackle some of my everyday health issues,” said Kannaway® Spokesperson Mark Walczak. “Kannaway’s products are easy to use, provide a lot of value and have given me back some of the flexibility I was lacking before taking them.”

Kannaway® is the first hemp lifestyle network to legally offer hemp-based botanical CBD wellness products. McClendon joins the Kannaway® Sports division, which aims to spread awareness of the many important benefits CBD offers for professional and amateur athletes, connecting former NFL athletes with the education and products they need to help them live happier, more fulfilling lives.

“Professional athletes and active consumers alike can enjoy the many potential antioxidant and anti-inflammatory benefits of CBD for overall wellness,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We are thankful that Mark Walczak is willing to share his experience with Kannaway’s products and educate people who may be hesitant to try CBD of its efficacy.”

You can learn more about the company and the other members of the Kannaway® Sports team here. For more information about Kannaway®, please visit

About Kannaway®

Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer CMW Media

P. 858-264-6600

[email protected]